Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products

Cytotherapy

Volumn 10, Issue 1, 2008, Pages 83-89

  Braakman, E ^a   Schuurhuis, G J ^b   Preijers, F W M B ^c   Voermans, C ^d   Theunissen, K ^e   van Riet, I ^f   Fibbe, W E ^g   Slaper Cortenbach, I ^h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CD34 selection; CliniMACS; HPC apheresis; Stem cell processing; Validation

Indexed keywords

REAGENT;

APHERESIS; ARTICLE; CD34 SELECTION; CELL COUNT; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; PURIFICATION; RETROSPECTIVE STUDY; T CELL DEPLETION; VALIDATION PROCESS;

EID: 38349175050     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701787650     Document Type: Article

References (15)

1. Ho, V. and Soiffer, RJ. (2001) The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood, 98, pp. 3192-3204.
2. Handgretinger, R., Lang, P. and Schumm, M. (1998) Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant, 21, pp. 987-993.
3. Lang, P., Klingebiel, T. and Bader, P. (2004) CD34+ cell transplants. Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant, 33, pp. 25-32.
4. Van Heeckeren, WJ, Vollweiler, J. and Fu, P. (2006) Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: In vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device. Br J Haematol, 132, pp. 42-55.
5. Samijn, JP, Boekhorst, PA te and Mondria, T. (2006) Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry, 77, pp. 46-50.
6. Verburg, RJ, Kruize, AA and Hoogen, FH van den (2001) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: Results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum, 44, pp. 754-760.
7. + cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother, 6, pp. 5-11.
8. Schumm, M., Lang, P. and Taylor, G. (1999) Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother, 8, pp. 209-218.
9. + cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACS device. J Hematother, 9, pp. 557-564.
10. + cell recovery. Stem Cells Dev, 14, pp. 734-739.
11. Watts, MJ, Somervaille, TC and Ings, SJ (2002) Variable product purity and functional capacity after CD34 selection: A direct comparison of the CliniMACS (v2.1) and Isolex 3001 (v2.5) clinical scale devices. Br J Haematol, 118, pp. 117-123.
12. Sutherland, DR, Anderson, L. and Keeney, M. (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother, 5, pp. 213-226.
13. Sutherland, R., Keeney, M. and Gratama, JW (2003) Current Protocols in Cytometry, John Wiley & Sons, Somerset
14. Arpaci, F., Cetin, T. and Özet, A. (2004) The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. J Clin Apheresis, 19, pp. 197-201.
15. + stem cell recovery after positive selection of 'overloaded' immunomagnetic columns. Stem Cells Dev, 14, pp. 740-743.